Pennsylvania HB 2527: An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose medication.

Status: Act No. 135 of 2022 (as of 2022-11-03)

State: Pennsylvania · Session: 2021-2022 · Bill: HB 2527

Sponsors: Quinn, C. Williams, Ciresi, Frankel, Gillen, Guenst, Hill-Evans, N. Nelson, Polinchock, Rowe, Sappey, Struzzi, Webster, Zimmerman

View Pennsylvania HB 2527 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.